Manufactured by:ProteoGenix
Save 20%RUO

Recombinant Human FGD4/FRABP Protein, N-His

Recombinant Human FGD4/FRABP Protein, N-His from ProteoGenix; catalogue ARO-P11522; research use only.

SKU:
ABM141961-1
Manufacturer SKU
ARO-P11522
Product type
Recombinant Proteins
Expression systemProkaryotic expression

Manufacturer provenance

Manufactured by:
ProteoGenix
Sold by:
ABMIUM
Fulfilled from:
Manufacturer facility or confirmed fulfilment location

Know who made it. See the evidence. Buy through one marketplace.

Product description

Introduction to Recombinant Human FGD4/FRABP Protein

Recombinant Human FGD4/FRABP Protein, also known as FGD4 or Frabin, is a protein that plays a crucial role in cell signaling and cytoskeletal organization. It belongs to the family of FGD (FYVE, RhoGEF, and PH domain-containing) proteins, which are involved in the regulation of Rho GTPases. The FGD4 gene is located on chromosome 12 and encodes for a protein of 1,178 amino acids. The recombinant form of this protein is produced through genetic engineering techniques and has various applications in the field of biotechnology and medicine.

Structure of Recombinant Human FGD4/FRABP Protein

The recombinant form of FGD4 protein is a 135 kDa protein with a complex structure consisting of various domains. It contains a FYVE domain, which is responsible for binding to phosphatidylinositol 3-phosphate (PI3P) and is involved in membrane trafficking. The protein also has a RhoGEF domain, which is responsible for activating Rho GTPases, a family of proteins that regulate cell signaling and cytoskeletal dynamics. Additionally, FGD4 has a PH domain, which is involved in protein-protein interactions and is known to play a role in cell signaling processes.

The structure of FGD4 protein also includes several other domains, such as a Dbl homology (DH) domain, a pleckstrin homology (PH) domain, and a SH3 domain. These domains are involved in the regulation of Rho GTPases and are crucial for the proper functioning of FGD4 protein.

Activity of Recombinant Human FGD4/FRABP Protein

The main activity of FGD4 protein is to act as a guanine nucleotide exchange factor (GEF) for Rho GTPases, specifically RhoA, Rac1, and Cdc42. This means that it facilitates the exchange of GDP for GTP on these GTPases, thereby activating them and initiating downstream signaling pathways. FGD4 has been shown to play a role in cell adhesion, migration, and proliferation through its regulation of Rho GTPases.

In addition to its role as a GEF, FGD4 also interacts with other proteins and is involved in various cellular processes. It has been found to interact with the protein tyrosine phosphatase PTPN13, which is involved in cell adhesion and migration. FGD4 has also been shown to interact with the cytoskeletal protein filamin A, which is involved in cell motility and signaling.

Application of Recombinant Human FGD4/FRABP Protein

The recombinant form of FGD4 protein has various applications in the field of biotechnology and medicine. One of its main applications is in the study of Rho GTPases and their role in cell signaling and cytoskeletal dynamics. Recombinant FGD4 protein can be used to study the activation and regulation of Rho GTPases, as well as their interactions with other proteins.

Another potential application of recombinant FGD4 protein is in drug discovery and development. As FGD4 plays a crucial role in cell adhesion, migration, and proliferation, targeting this protein could have therapeutic implications for diseases such as cancer, where these processes are dysregulated. Recombinant FGD4 protein can be used in screening assays to identify potential inhibitors or activators of FGD4, which could be further developed into drugs.

Furthermore, FGD4 has been implicated in various diseases, including Charcot-Marie-Tooth disease type 4H, which is a hereditary neuropathy. Recombinant FGD4 protein can be used to study the molecular mechanisms underlying this disease and potentially develop targeted therapies.

ProteoGenix catalogue number ARO-P11522. For research use only.

Host: Escherichia coli (E.coli); Expression system: Prokaryotic expression; Molecular weight: 24.84 kDa; Fragment: Ser545-Glu742; Buffer: Lyophilized from a solution in PBS pH 7.4, 0.02% NLS, 1mM EDTA, 4% Trehalose, 1% Mannitol..

Available configurations: 50ug, 100ug, 1mg.

Download the manufacturer datasheet

Key facts & specifications
Also known as
Actin filament-binding protein frabin, ZFYVE6, FYVE, RhoGEF and PH domain-containing protein 4, FGD1-related F-actin-binding protein, FGD4, FRABP, Zinc finger FYVE domain-containing protein 6
Host species
E. coli
Source organism
Human
Molecular weight
24.84 kDa
Sequence fragment
Ser545-Glu742
Sequence
STAELGKRAPRWIRDNEVTMCMKCKEPFNALTRRRHHCRACGYVVCWKCSDYKAQLEYDGGKLSKVCKDCYQIISGFTDSEEKKRKGILEIESAEVSGNSVVCSFLQYMEKSKPWQKAWCVIPKQDPLVLYMYGAPQDVRAQATIPLLGYVVDEMPRSADLPHSFKLTQSKSVHSFAADSEELKQKWLKVILLAVTGE
Technical note
For research use only.
Identifiers & database references
Manufacturer SKU
ARO-P11522
UniProt accession
Q96M96
Storage, stability & shipping
Storage conditions
4°C for short term (1 week), -20°C or -80°C for long term (avoid freezing/thawing cycles; addition of 20-40% glycerol improves cryoprotection)
Shipped at
Dry Ice
Compliance & documents
ISO certifications
ISO 9001:2023, ISO 14001: 2023
Datasheet
Open datasheet
Frequently asked questions
Who manufactured this product?

This product is manufactured by ProteoGenix and sold through ABMIUM without relabelling.

Can ABMIUM ship this product internationally?

ABMIUM supports global orders. Availability, shipping requirements and applicable import arrangements are confirmed before fulfilment where required.

Can I check suitability before ordering?

Yes. Send your target, sample, application and experimental conditions through ABMIUM MATCH or technical support.

Is this product for clinical use?

Unless the listing expressly states otherwise, ABMIUM products are supplied for research use only and are not for diagnostic or therapeutic use.

ProteoGenix
£195.00£156.00